Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.

Krishnan Natesan S, Wu W, Cutright JL, Chandrasekar PH.

Diagn Microbiol Infect Dis. 2012 Nov;74(3):272-7. doi: 10.1016/j.diagmicrobio.2012.06.030. Epub 2012 Aug 14.

PMID:
22897872
2.

Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.

Krishnan-Natesan S, Manavathu EK, Cutright JL, Chandrasekar PH.

Int J Antimicrob Agents. 2010 Jul;36(1):33-6. doi: 10.1016/j.ijantimicag.2010.02.020. Epub 2010 Apr 18.

PMID:
20400270
3.

In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.

Manavathu EK, Cutright JL, Chandrasekar PH.

Antimicrob Agents Chemother. 2005 Jan;49(1):428-30.

4.

In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.

Ganesan LT, Manavathu EK, Cutright JL, Alangaden GJ, Chandrasekar PH.

Clin Microbiol Infect. 2004 Nov;10(11):961-6.

5.

Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.

Chandrasekar PH, Cutright JL, Manavathu EK.

Clin Microbiol Infect. 2004 Oct;10(10):925-8.

6.

CAN-296-P is effective against cutaneous candidiasis in guinea pigs.

Ben-Josef AM, Cutright JL, Manavathu EK, Sobel JD.

Int J Antimicrob Agents. 2003 Aug;22(2):168-71.

PMID:
12927959
7.

Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.

Chandrasekar PH, Cutright JL, Manavathu EK.

Diagn Microbiol Infect Dis. 2001 Dec;41(4):211-4.

PMID:
11777662
8.

Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis.

Leigh JE, Barousse M, Swoboda RK, Myers T, Hager S, Wolf NA, Cutright JL, Thompson J, Sobel JD, Fidel PL Jr.

J Infect Dis. 2001 Jan 15;183(2):277-285. Epub 2000 Dec 13.

PMID:
11120933
10.

In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.

Abraham OC, Manavathu EK, Cutright JL, Chandrasekar PH.

Diagn Microbiol Infect Dis. 1999 Jan;33(1):7-11.

PMID:
9990469
11.

Organism-dependent fungicidal activities of azoles.

Manavathu EK, Cutright JL, Chandrasekar PH.

Antimicrob Agents Chemother. 1998 Nov;42(11):3018-21.

12.

Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen.

Fidel PL Jr, Ginsburg KA, Cutright JL, Wolf NA, Leaman D, Dunlap K, Sobel JD.

J Infect Dis. 1997 Sep;176(3):728-39.

PMID:
9291322
13.

Efficacy of D0870 treatment of experimental Candida vaginitis.

Fidel PL Jr, Cutright JL, Sobel JD.

Antimicrob Agents Chemother. 1997 Jul;41(7):1455-9.

14.

A murine model of Candida glabrata vaginitis.

Fidel PL Jr, Cutright JL, Tait L, Sobel JD.

J Infect Dis. 1996 Feb;173(2):425-31.

PMID:
8568305
15.

Supplemental Content

Loading ...
Support Center